• Company
• Promotion of new drugs·biosimilars at KOS annual conference
• by Son, Hyung Min Dec 2, 2024 05:49am

• Company
• Antibody drug 'Fasenra' lands in KOR with EGPA indication
• by Eo, Yun-Ho Dec 2, 2024 05:49am

• Company
• Industry speeds up the development of bispecific antibodies
• by Son, Hyung Min Dec 2, 2024 05:49am

• Company
• Is RWD needed for post-listing control of PE exempt drugs?
• by Eo, Yun-Ho Dec 2, 2024 05:49am

• Company
• oHCM drug 'Camzyos' gets greenlight for reimb
• by Eo, Yun-Ho Nov 29, 2024 05:55am

• Company
• Deregulate to foster new modalities like ADC, gene therapy
• by Son, Hyung Min Nov 29, 2024 05:55am

• Company
• Samsung Bioepis names Kyung-Ah Kim as new CEO
• by Nov 29, 2024 05:55am

• Company
• 'Global obesity drug market 79 times bigger than Korea'
• by Son, Hyung Min Nov 29, 2024 05:55am

• Company
• Sales rights for Viviant·Tuvero·Akarb to be transferred
• by Kim JiEun Nov 28, 2024 05:55am

• Company
• Lilly appoints Stacie Liu to head the CardioMetabolic Health
• by Eo, Yun-Ho Nov 28, 2024 05:54am